What is DC Bead™?

DC Bead is used in transarterial chemoembolisation (TACE). This is a minimally invasive (non-surgical) procedure performed by an interventional radiologist, and is used in the local treatment of tumours in patients with hepatocellular carcinoma (HCC).

Not all indications may be available in all territories.

View More

What is Catheter Embolisation?

Embolisation therapy is a minimally invasive (non-surgical) treatment that occludes or blocks one or more blood vessels or vascular channels of malformations (abnormality)

Not all indications may be available in all territories.

View More

Experience

The benefits of DC Bead are supported by over 150 peer reviewed papers and are now recognised in the European Clinical Practice Guidelines for HCC4,5


Survival Data

DC Bead is challenging survival expectations for intermediate HCC patients2, 3


History

Launched in 2005 DC Bead is the leading drug eluting bead that has been used to treat patients requiring transarterial chemoembolisation (TACE) in malignant hypervascularised tumour(s) and malignant colorectal cancer metastasised in the liver


DC Bead

 

The gold-standard Drug-Eluting Bead, DC Bead™ is supported by ten years' experience and more than 80 publications reporting outcomes in over 3000 HCC patients.2